About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials | 1,276 Studies Recruiting

Clinical TrialsLupus

Lupus Clinical Trials

Browse 1,276 clinical trials for lupus. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 101-120 of 1,276 trials

RecruitingSubgrouping SLE - a New Approach to Understand the Pathogenesis and Improve TreatmentThe goal of this observational study is to investigate different phenotypes among patients with SLE and to compare with matched general population controls.NCT07102030·Stockholm Not yet recruitingAn Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE)The purpose of this First-In-Human (FIH), Phase 1, open-label, ascending dose study is to determine safety and tolerability of DKB903, in participants with Rheumatoid Arthritis…NCT07923747 UnknownHaematological Indices in Systemic Lupus ErythematosusThe aim of this study is to investigate the value of several hematological indices such as: * neutrophil-lymphocyte ratio. * platelet-lymphocyte ratio.NCT04110184 Active not recruitingA Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)The purpose of this study is to establish the tolerability, preliminary efficacy, and pharmacokinetics of CC-97540 in participants with severe, refractory autoimmune diseases…NCT05869955·Aurora, Colorado and 45 others

Related Searches

sletrials systemic lupustrials

Data from ClinicalTrials.govTerms

Enrolling by invitationCHT105 for the Treatment of Refractory Lupus NephritisSystemic lupus erythematosus (SLE) is the most common systemic autoimmune disease in China.NCT07517536·Nanjing, Jiangsu

CompletedBelimumab In Early Systemic Lupus ErythematosusTo investigate the efficacy of belimumab in early SLE patients (disease duration less than 6 months).NCT04956484·Beijing, Dongcheng

UnknownExploratory Study of DHA in Systemic Lupus Erythematosus PatientsThe primary objective of the study is to assess the efficacy of DHA in patients with SLE.NCT03396393

CompletedRandomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus ErythematosusOBJECTIVES: I.NCT00006133·Birmingham, Alabama and 16 others

CompletedRelevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune DiseasesNo drug treatment is completely free of risk and lack of response, adverse events and poor adherence may affect its effectiveness.NCT03122431·São Paulo

WithdrawnPharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune DiseasesThe purpose of this pharmacokinetic (PK) study is to describe the PK profile of ianalumab following s.c. administration in Chinese participants with systemic lupus erythematosus…NCT06411639

CompletedSystemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)SPOCS is an international, multicenter, prospective observational cohort study with bi-annual study visits over a 3-year follow-up designed to systematically describe the…NCT03189875·Phoenix, Arizona and 134 others

CompletedOpen-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus ErythematosusSystemic lupus erythematosus is a serious and potentially life-threatening condition with significant unmet medical need.NCT01769937·Lansing, Michigan

WithdrawnA Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or LupusBackground: Systemic lupus erythematosus (SLE), also called lupus, is a disease that causes the body s immune system to attack healthy tissue.NCT06238531·Bethesda, Maryland

UnknownStudy of Leukocyte Populations in Patients With Chronic InflammatoryExploration of pathophysiological mechanisms in chronic inflammatory rheumatism and rare systemic autoimmune diseases with the objective of identifying therapeutic targets.NCT04749875·Le Kremlin-Bicêtre

UnknownObservational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesThis study investigates the genetic architecture of Neutrophil-Mediated Inflammatory Skin Diseases.NCT01952275·Zurich, Canton of Zurich

CompletedA Study of DS-7011a in Patients With Systemic Lupus ErythematosusSystemic lupus erythematosus (SLE) is a systemic chronic autoimmune disease characterized by autoantibody production, inflammation, and tissue damage in multiple organs.NCT05638802·Anniston, Alabama and 19 others

UnknownThe Lupus prEGnAnCY Cohort: An International Prospective Cohort of Lupus PregnanciesThe goal is to evaluate adverse pregnancy outcomes (APO), their predictors and potential preventive therapies, such as aspirin (ASA).NCT03746028·Montreal, Quebec

CompletedBLYS and IFN in SLEThis protocol tests whether changes in BLyS or IFN can be detected in a normal immune response to a vaccine and, if so, whether the response differs between those with lupus and…NCT00611611·Birmingham, Alabama

UnknownSerum Ceramides Level in Systemic Lupus Erythematosus (SLE) Patients as a Novel Marker for Renal Impairment1. Estimation of serum ceramides level in SLE patients as anovel marker for renal impairment 2.NCT04256577

CompletedThe Role of ITGAM in Systemic Lupus ErythematosusStudy to examine the role of ITGAM molecule in normal control subjects with known genetic variation in the ITGAM gene.NCT01230112·Manhasset, New York

PreviousPage 6 of 64Next